TACSTD2 and endometrial cancer: Researchers have found that bicistronic cyclin D1-TROP2 mRNA was frequently expressed in ovarian, colonic and endometrial cancers, and both the TROP2 and cyclin D1 moieties in the chimera could induce cell malignant transformation [9].